Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 311 to 320 of 2418

TitleReference numberPublishedLast updated
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and overTA893
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphomaTA677
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitorTA670
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Brodalumab for treating moderate to severe plaque psoriasisTA511
Brolucizumab for treating diabetic macular oedemaTA820
Brolucizumab for treating wet age-related macular degenerationTA672
Bronchial thermoplasty for severe asthmaIPG635
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribingNG117

Results per page

  1. 10
  2. 25
  3. 50
  4. All